New Leap Forward for...
2nd April 2020 Product update: PCR Biosystems
PCR Biosystems Produce COVID-19 RT-qPCR Reagent to Meet Demand
PCR Biosystems, the UK-based PCR experts, are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to the UK and global healthcare systems as demand for testing rises.
To meet current and upcoming requirements and ensure supply chain security, PCR Biosystems has already significantly increased – and will continue to increase – manufacture of qPCRBIO Probe 1-Step Go and all other critical reagents for rapid and sensitive RT-qPCR.
PCR Biosystems can manufacture enough reagent daily for 4 million reactions – which is sufficient for millions of diagnostic tests.
Recent changes at PCR Biosystems include implementing shift-based working for production, assembly and order fulfilment, with three separate teams working seven days a week. Also, two commercial teams have been fully trained in reserve to provide operational support if required.
The company is working closely with customers, partners and suppliers, and is ready to implement further contingency plans if necessary, to ensure the uninterrupted supply of PCR reagents to customers around the world.
qPCRBIO Probe 1-Step Go is a universal probe kit designed for fast and sensitive probe-based RT-qPCR. It’s PCR Biosystems’s recommended product for COVID-19 diagnostic tests, supporting the detection, quantification and typing of the SARS-CoV-2 virus.
All that’s required is the addition of specific primers and probes, together with the swab extract and water. qPCRBIO Probe 1-Step Go is compatible with all qPCR instruments and is engineered for use on a wide range of probe technologies including TaqMan®, Scorpions® and molecular beacon probes. In March 2020, PCR Biosystems introduced bulk pack sizes of this key product, to further support customers in high-throughput COVID-19 testing.
Date Published: 2nd April 2020
Source article link: View
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.
New Leap Forward for SARS-CoV-2